Company Performance Metrics
- Izhar Hasan: Co-Founder & Chief Scientific Officer
- Dr. Joel S Ross: Co-Founder & CEO
RH/Nanopharma is a pharmaceutical research and development company dedicated to treating, preventing, slowing and reversing inflammatory diseases.
Inflammation is at the heart of conditions such as osteoarthritis,type 2 diabetes, acute and chronic pain, traumatic brain injury, Alzheimer’s Disease, Dry Eye Disease (DED), inflammatory bowel
disorders such as ulcerative colitis and Crohn’s Disease.
RH NANO has reformulated a medication called salsalate which has been used for arthritis and diabetes for over 100 years. RH NANO is proud to be the first pharmaceutical company to successfully produce a nanoparticle of salsalate to be used in all the above mentioned inflammatory disorders. Salsalate in both standard and nanoparticle size is the safest anti-inflammatory/analgesic medicine known to physicians.
